This site is intended for healthcare professionals
News

EU approves Ultomiris for patients with atypical hemolytic uremic syndrome.- Alexion Pharma

Read time: 1 mins
Last updated:30th Jun 2020
Published:30th Jun 2020
Condition: Haemolytic Uremic Syndrome (aHUS)
Type: drug
Register free for full access to medthority.com